Navigation Links
Novasep and Mega Sign a Strategic Technology Partnership to Develop Whey Treatment Solutions for the Dairy Industry
Date:11/10/2010

Novasep and Mega Sign a Strategic Technology... -- POMPEY, France and STRAZ POD RASKEM, Czech Republic, November 10, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Food & Beverages, Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, Joint Ventures Click to view news release full screen  

Novasep and Mega Sign a Strategic Technology Partnership to Develop Whey Treatment Solutions for the Dairy Industry

   

Electrodialysis and Manufacturing Process Companies Come Together to Design the Most Cost-Effective Whey Demineralization Solutions Offering Guaranteed Performance

POMPEY, France and STRAZ POD RASKEM, Czech Republic, November 10, 2010 /PRNewswire/ -- Novasep, a leading supplier of manufacturing solutions to the life sciences industry, and Mega, a technology leader in electrodialysis, today announce a strategic technology partnership in the field of whey treatment. The companies will combine Mega's advanced electrodialysis technology with the whey demineralization solutions from Novasep Process, the biomolecule division of Novasep that provides purification process lines for the fields of bio-industries, food ingredients, and biopharmaceuticals. This will enable both partners to propose a range of cost-effective processes for all qualities of demineralized whey, with guaranteed performance.

The alliance brings a significant addition to the technology portfolio of Novasep Process, being able to now offer an even wider range of manufacturing process solutions to customers in the dairy industry. The cooperation will also provide Novasep Process with better access to Central and Eastern European as well as Indian markets, in which Mega has a strong commercial presence. Conversely, it will also increase the visibility of Mega's electrodialysis technology in the other geographic zones through the active promotion by Novasep and through its integration within global processes guaranteed by Novasep.

Today, alternate whey demineralization solutions using electrodialysis are energy-consuming and require frequent replacement of membranes. On the contrary, Mega's proprietary technology reduces electricity consumption and provides a membrane lifetime guarantee for up to 4 years, strongly minimizing maintenance costs. Mega and Novasep Process have designed a range of processes optimized for any crude and demineralized whey qualities, associating Mega's technology with Novasep Process technologies including ion exchange and nanofiltration (NF). Through this alliance, Novasep Process' offering includes process design and development, turn-key system engineering, supply and commissioning, customer service and consumables.

"I am delighted with Novasep Process' cooperation with Mega, a company that is a technology leader in electro-membrane processes," said Antoine Baule, president of Novasep Process. "This alliance further enriches Novasep Process' portfolio of technologies and will enable us to better serve our clients in the dairy industry for their whey processing requirements."

This alliance in the process field enhances the capabilities of both partners to better serve their respective customers in the field. Lubos Novak, president and CEO of Mega, added, "Novasep is a global leader in process solutions for food ingredient manufacturing. This partnership will enable both companies to design strongly enhanced solutions, through collaborative product and process development."

About MEGA

MEGA is a specialist in electrodialysis (ED), fully integrated in the design and production of ED membranes as well as ED skids and systems. Its unique technology currently has the highest performance of any on the market, and is applied in a variety of processes, including water treatment, purification of organic solutions and whey demineralization.

About Novasep

Novasep develops, markets and operates innovative technologies providing life science industries with safe and cost-effective production of active molecules. The global manufacturing solutions offered by Novasep include process development services; purification equipment and systems; contract manufacturing services; and complex active molecules. The applications of Novasep's offering cover the pharmaceutical, biopharmaceutical, food, functional ingredients and bio-industries markets.

Website: http://www.mega.cz


'/>"/>
SOURCE Novasep
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MonoSol Rx Issued Strategic U.S. Patent Governing the Manufacturing of Pharmaceutical Films
2. ThermoGenesis Reports 35 Percent Increase in First Quarter 2011 Revenues, Adds Strategic Advisor and Inks China Distribution Deal With Nanshan Memorial Medical Institute
3. Covance and sanofi-aventis Finalize Agreements for 10-year Strategic R&D Alliance
4. Pilgrim Software and Portford Solutions Sign Strategic Reseller Agreement
5. Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs
6. Savient Pharmaceuticals Provides Update on Strategic Alternatives Process
7. Frost & Sullivan: Strategic Partnerships Crucial to Medical Device Success
8. International SOS Establishes a Strategic Alliance With RMSI
9. IDEV Technologies Completes $46 Million Preferred Stock Financing With Piper Jaffray and Additional Strategic Investor
10. Pfizer To Review Strategic Alternatives For Capsugel
11. Objet Geometries and Javelin Technologies Form Strategic Distribution Partnership for 3D Printers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... a leader in post-acute health care, have expanded their existing home health joint ... Health. , AccentCare has been operating a joint venture home health company with ...
(Date:10/12/2017)... ... 2017 , ... Dr. Parsa Mohebi, the Los Angeles based ... the newly revamped Cosmetic Town journal section, featuring articles written by ... as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I enjoy ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... Mich. (PRWEB) , ... October 12, 2017 , ... ... has been named one of Michigan’s 2017 Best and Brightest in Wellness® by ... Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to ...
Breaking Medicine News(10 mins):